Strategic identification of in vitro metabolites of 13-desmethyl spirolide C using liquid chromatography/high-resolution mass spectrometry

Rapid Communications in Mass Spectrometry

Volumn 26, Issue 3, 2012, Pages 345-354

  Hui, Joseph P M ^a   Stuart Grossert, J ^a,b   Cutler, Murray J ^a,c,d   Melanson, Jeremy E ^a  

^a NATIONAL RESEARCH COUNCIL CANADA   (Canada)

^b DALHOUSIE UNIVERSITY   (Canada)

^c DALHOUSIE UNIVERSITY   (Canada)

^d Beatrice Hunter Cancer Research Institute   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

BIOMOLECULES; HYDROXYLATION; IONS; LIQUID CHROMATOGRAPHY; MASS SPECTROMETRY; METABOLISM; METHANOL; PHYSIOLOGY;

13-DESMETHYL SPIROLIDE C; ACCURATE MASS MEASUREMENTS; CYCLIC IMINES; FRAGMENT IONS; HIGH RESOLUTION MASS SPECTROMETRY; HUMAN LIVER MICROSOMES; IN-VITRO; LIQUID CHROMATOGRAPHY-HIGH RESOLUTION MASS SPECTROMETRIES; MOLECULAR FORMULAE; PRECURSOR IONS;

METABOLITES;

EID: 84855648179     PISSN: 09514198     EISSN: 10970231     Source Type: Journal    
DOI: 10.1002/rcm.5336     Document Type: Article

References (43)

1. T. Seki, M. Satake, L. Mackenzie, H. F. Kaspar, T. Yasumoto,. Gymnodimine, a new marine toxin of unprecedented structure isolated from New Zealand oysters and the dinoflagellate, Gymnodinium sp. Tetrahedron Lett. 1995, 36, 7093.
2. C. O. Miles, A. L. Wilkins, D. J. Stirling, A. L. MacKenzie,. New analogue of gymnodimine from a Gymnodinium species. J. Agric. Food Chem. 2000, 48, 1373.
3. T. Hu, I. W. Burton, A. D. Cembella, J. M. Curtis, M. A. Quilliam, J. A. Walter, J. L. Wright,. Characterization of spirolides A, C, and 13-desmethyl C, new marine toxins isolated from toxic plankton and contaminated shellfish. J. Nat. Prod. 2001, 64, 308.
4. N. Takada, N. Umemura, K. Suenaga, D. Uemura,. Structural determination of pteriatoxins A, B and C, extremely potent toxins from the bivalve Pteria penguin. Tetrahedron Lett. 2001, 42, 3495.
5. A. I. Selwood, C. O. Miles, A. L. Wilkins, R. van Ginkel, R. Munday, F. Rise, P. McNabb,. Isolation, structural determination and acute toxicity of pinnatoxins E, F and G. J. Agric. Food Chem. 2010, 58, 6532.
6. T. Hu, J. M. Curtis, Y. Oshima, M. A. Quilliam, J. A. Walter, W. M. Watson-Wright, J. L. C. Wright,. Spirolides B and D, two novel macrocycles isolated from the digestive glands of shellfish. J. Chem. Soc. Chem. Commun. 1995, 2159.
7. A. D. Cembella, N. I. Lewis, M. A. Quilliam,. Spirolide composition of micro-extracted pooled cells isolated from natural plankton assemblages and from cultures of the dinoflagellate Alexandrium ostenfeldii. Nat. Toxins 1999, 7, 197.
8. L. Sleno, M. J. Chalmers, D. A. Volmer,. Structural study of spirolide marine toxins by mass spectrometry. Part II. Mass spectrometric characterization of unknown spirolides and related compounds in a cultured phytoplankton extract. Anal. Bioanal. Chem. 2004, 378, 977.
9. L. Sleno, A. J. Windust, D. A. Volmer,. Structural study of spirolide marine toxins by mass spectrometry. Part I. Fragmentation pathways of 13-desmethyl spirolide C by collision-induced dissociation and infrared multiphoton dissociation mass spectrometry. Anal. Bioanal. Chem. 2004, 378, 969.
10. T. Hu, J. M. Curtis, J. A. Walter, J. L. C. Wright,. Characterization of biologically inactive spirolides E and F: Identification of the spirolide pharmacophore. Tetrahedron Lett. 1996, 37, 7671.
11. P. Ciminiello, C. Dell'Aversano, E. Fattorusso, S. Magno, L. Tartaglione, M. Cangini, M. Pompei, F. Guerrini, L. Boni, R. Pistocchi,. Toxin profile of Alexandrium ostenfeldii (Dinophyceae) from the northern Adriatic Sea revealed by liquid chromatography-mass spectrometry. Toxicon 2006, 47, 597.
12. B. Christian, A. Below, N. Dressler, O. Scheibner, B. Luckas, G. Gerdts,. Are spirolides converted in biological systems?-A study. Toxicon 2008, 51, 934.
13. J. Aasen, S. L. MacKinnon, P. LeBlanc, J. A. Walter, P. Hovgaard, T. Aune, M. A. Quilliam,. Detection and identification of spirolides in Norwegian shellfish and plankton. Chem. Res. Toxicol. 2005, 18, 509.
14. S. L. MacKinnon, J. A. Walter, M. A. Quilliam, A. D. Cembella, P. Leblanc, I. W. Burton, W. R. Hardstaff, N. I. Lewis,. Spirolides isolated from Danish strains of the toxigenic dinoflagellate Alexandrium ostenfeldii. J. Nat. Prod. 2006, 69, 983.
15. J. S. Roach, P. LeBlanc, N. I. Lewis, R. Munday, M. A. Quilliam, S. L. MacKinnon,. Characterization of a dispiroketal spirolide subclass from Alexandrium ostenfeldii. J. Nat. Prod. 2009, 1237.
16. P. Ciminiello, C. Dell'Aversano, E. Fattorusso, M. Forino, L. Grauso, L. Tartaglione, F. Guerrini, R. Pistocchi,. Spirolide toxin profile of Adriatic Alexandrium ostenfeldii cultures and structure elucidation of 27-hydroxy-13,19-didesmethyl spirolide C. J. Nat. Prod. 2007, 70, 1878.
17. P. Ciminiello, C. Dell'aversano, E. D. Iacovo, E. Fattorusso, M. Forino, L. Grauso, L. Tartaglione, F. Guerrini, L. Pezzolesi, R. Pistocchi,. Characterization of 27-hydroxy-13-desmethyl spirolide C and 27-oxo-13,19- didesmethyl spirolide C. Further insights into the complex Adriatic Alexandrium ostenfeldii toxin profile. Toxicon 2010, 56, 1327.
18. C. B. Wandscheer, N. Vilariño, B. A. Espiña, M. C. Louzao, L. M. Botana,. Human muscarinic acetylcholine receptors are a target of the marine toxin 13-desmethyl C spirolide. Chem. Res. Toxicol. 2010, 23, 1753.
19. EFSA Panel on Contaminants in the Food Chain (CONTAM); Scientific Opinion on marine biotoxins in shellfish-Cyclic imines (spirolides, gymnodimines, pinnatoxins and pteriatoxins). EFSA J. 2010, 8, 1628.
20. J. Rittle, M. T. Green,. Cytochrome P450 compound I: capture, characterization, and C-H bond activation kinetics. Science 2010, 330, 933.
21. N. Hariparsad, R. S. Sane, S. C. Strom, P. B. Desai,. In vitro Methods: in human drug biotransformation research: Implications for cancer chemotherapy. Toxicol. In Vitro 2006, 20, 135.
22. M. Holcapek, L. Kolarova, M. Nobilis,. High-performance liquid chromatography-tandem mass spectrometry in the identification and determination of phase I and phase II drug metabolites. Anal. Bioanal. Chem. 2008, 391, 59.
23. R. J. Mortishire-Smith, D. O'Connor, J. M. Castro-Perez, J. Kirby,. Accelerated throughput metabolic route screening in early drug discovery using high-resolution liquid chromatography/quadrupole time-of-flight mass spectrometry and automated data analysis. Rapid Commun. Mass Spectrom. 2005, 19, 2659.
24. K. Kittler, A. Preiss-Weigert, A. These,. Identification strategy using combined mass spectrometric techniques for elucidation of phase I and phase II in vitro metabolites of lipophilic marine biotoxins. Anal. Chem. 2010, 82, 9329.
25. C. García, A. Rodriguez-Navarro, J. C. Díaz, R. Torres, N. Lagos,. Evidence of in vitro glucuronidation and enzymatic transformation of paralytic shellfish toxins by healthy human liver microsomes fraction. Toxicon 2009, 53, 206.
26. C. García, A. Barriga, J. C. Díaz, M. Lagos, N. Lagos,. Route of metabolization and detoxication of paralytic shellfish toxins in humans. Toxicon 2010, 55, 135.
27. A. Tolonen, M. Turpeinen, O. Pelkonen,. Liquid chromatography-mass spectrometry in in vitro drug metabolite screening. Drug Discov. Today 2009, 14, 120.
28. K. A. Youdim, K. C. Saunders,. A review of LC-MS techniques and high-throughput approaches used to investigate drug metabolism by cytochrome P450s. J. Chromatogr. B 2010, 878, 1326.
29. M. Yao, L. Ma, E. Duchoslav, M. Zhu,. Rapid screening and characterization of drug metabolites using multiple ion monitoring dependent product ion scan and postacquisition data mining on a hybrid triple quadrupole-linear ion trap mass spectrometer. Rapid Commun. Mass Spectrom. 2009, 23, 1683.
30. R. Xu, M. Manuel, J. Cramlett, D. B. Kassel,. A high throughput metabolic stability screening workflow with automated assessment of data quality in pharmaceutical industry. J. Chromatogr. A 2010, 1217, 1616.
31. K. P. Bateman, J. Castro-Perez, M. Wrona, J. P. Shockcor, K. Yu, R. Oballa, D. A. Nicoll-Griffith,. MSE with mass defect filtering for in vitro and in vivo metabolite identification. Rapid Commun. Mass Spectrom. 2007, 21, 1485.
32. K. P. Bateman, M. Kellmann, H. Muenster, R. Papp, L. Taylor,. Quantitative-qualitative data acquisition using a benchtop Orbitrap mass spectrometer. J. Am. Soc. Mass Spectrom. 2009, 20, 1441.
33. R. Ramanathan, M. Jemal, S. Ramagiri, Y. Q. Xia, W. G. Humpreys, T. Olah, W. A. Korfmacher,. It is time for a paradigm shift in drug discovery bioanalysis: From SRM to HRMS. J. Mass Spectrom. 2011, 46, 595.
34. M. Furlong, A. Bessire, W. Song, C. Huntington, E. Groeber,. Use of high-resolution mass spectrometry to investigate a metabolite interference during liquid chromatography/tandem mass spectrometric quantification of a small molecule in toxicokinetic study samples. Rapid Comm. Mass Spectrom. 2010, 24, 1902.
35. R. E. Pearce, W. Lu, Y. Wang, J. P. Uetrecht, M. A. Correia, J. S. Leeder,. Pathways of carbamazepine bioactivation in vitro. III. The role of human cytochrome P450 enzymes in the formation of 2,3-dihydroxycarbamazepine. Drug Metab. Dispos. 2008, 36, 1637.
36. P. Blay, J. P. M. Hui, J. Chang, J. E. Melanson,. Screening for multiple classes of marine biotoxins by liquid chromatography-high-resolution mass spectrometry. Anal. Bioanal. Chem. 2011, 400, 577.
37. J. S. Grossert, P. D. Fancy, R. L. White,. Fragmentation pathways of negative ions produced by electrospray ionization of acyclic dicarboxylic acids and derivatives. Can. J. Chem. 2005, 83, 1878.
38. P. Baranczewski, A. Stańczak, K. Sundberg, R. Svensson, Å. Wallin, J. Jansson, P. Garberg, H. Postlind,. Introduction to in vitro estimation of metabolic stability and drug interactions of new chemical entities in drug discovery and development. Pharmacol. Rep. 2006, 58, 453.
39. A. F. Nassar, P. F. Hollenberg, J. Scatina,. Drug Metabolism Handbook: Concepts and Applications. John Wiley, Chichester, 2009.
40. Y. Bourne, Z. Radic, R. Araoz, T. T. Talley, E. Benoit, D. Servent, P. Taylor, J. Molgo, P. Marchot,. Structural determinants in phycotoxins and AChBP conferring high affinity binding and nicotinic AChR antagonism. Proc. Natl. Acad. Sci. USA 2010, 107, 6076.
41. J. Yang, M. Jamei, K. R. Yeo, G. T. Tucker, A. Rostami-Hodjegan,. Prediction of intestinal first-pass drug metabolism. Curr. Drug Metab. 2007, 8, 676.
42. B. Espiña, P. Otero, M. C. Louzao, A. Alfonso, L. M. Botana,. 13-Desmethyl spirolide-C and 13,19-didesmethyl spirolide-C trans-epithelial permeabilities: Human intestinal permeability modelling. Toxicology 2011, 287, 69.
43. R. Munday, in Seafood and Freshwater Toxins: Pharmacology, Physiology and Detection, (2nd edn.), (Ed.:, L. M. Botana,). CRC Press (Taylor and Francis Group), Boca Raton, FL, 2008.